Bladder cancer biomarkers and their role in surveillance and screening.
about
Specific survivin dual fluorescence resonance energy transfer molecular beacons for detection of human bladder cancer cells.MicroRNAs as biomarkers associated with bladder cancer.Expression levels of transcription factors c-Fos and c-Jun and transmembrane protein HAb18G/CD147 in urothelial carcinoma of the bladder.FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcriptsOncoprotein DEK as a tissue and urinary biomarker for bladder cancer.Long interspersed nuclear element-1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potentialDetermination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancerRationale for an early detection program for bladder cancerBiomarkers for prognosis and treatment selection in advanced bladder cancer patients.The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer.Evaluation of MMP-2, MMP-9, TIMP-1, TIMP-2, NGAL and MMP-9/NGAL complex in urine and sera from patients with bladder cancer.Characteristic patterns of microRNA expression in human bladder cancerClinical states model for biomarkers in bladder cancerThe efferent segment in continent cutaneous urinary diversion: a comprehensive review of the literature.Republished: non-invasive urine based tests for the detection of bladder cancer.High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival.Network views for personalized medicine.HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker.Upregulation of tissue and urinary nicotinamide N-methyltransferase in bladder cancer: potential for the development of a urine-based diagnostic test.
P2860
Q31039602-303E6D45-6936-4240-9396-74BFE12307B5Q33642335-06FE77A3-0597-414B-8B88-96D581F52086Q33672321-14C3C7DD-4D45-44D5-BA2B-853EB3ED7CFCQ33745140-613C3997-B746-4F73-9AA6-E6F2E51D07F9Q33755486-A0A2637D-1EF1-4108-A8BF-209A7F9B6559Q33929637-FCBE5DC3-76AC-4324-A7F8-81E0C873B4A8Q34277612-FC8D8F49-F4C5-4A1A-B5F1-60CE344AAD14Q34515117-252D58F9-0BD6-42A3-B449-C721CE51400BQ35125733-CB6DF00B-CDAC-4AEE-A88D-3B0F0F559FF3Q35671292-836D7D87-3FE8-4364-A2E0-7B032FB326EFQ36019595-0847CA6C-5BA7-4C55-A9D7-32D266558160Q36085915-1F247D8E-61FE-4440-ACE2-97BA5C3CF500Q36516905-11245301-2C14-430E-A49E-86EE3397B7A4Q36995765-59279284-C5E3-4D7D-A36A-2C735C6DCA7EQ37885452-A99E1B41-AE9F-43A0-8DAE-4284B47FFA34Q38107899-0BD1D6D2-872B-4ED8-95D7-1D25A3067442Q38906984-E6BD6FCA-41C1-48F5-AFBA-229AE2328F91Q42694013-76850344-3D7B-4074-B217-A530BDFB5209Q47834018-08ED5DA0-DE47-451C-82E3-38D5790F1A6FQ54286221-81F63ED3-6090-410F-9497-F74BD0866166
P2860
Bladder cancer biomarkers and their role in surveillance and screening.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bladder cancer biomarkers and their role in surveillance and screening.
@en
Bladder cancer biomarkers and their role in surveillance and screening.
@nl
type
label
Bladder cancer biomarkers and their role in surveillance and screening.
@en
Bladder cancer biomarkers and their role in surveillance and screening.
@nl
prefLabel
Bladder cancer biomarkers and their role in surveillance and screening.
@en
Bladder cancer biomarkers and their role in surveillance and screening.
@nl
P2093
P2860
P1476
Bladder cancer biomarkers and their role in surveillance and screening.
@en
P2093
Angela A G Van Tilborg
Chris H Bangma
Ellen C Zwarthoff
P2860
P356
10.1111/J.1442-2042.2008.02174.X
P577
2009-01-01T00:00:00Z